Skip to main content

Lanchbury Jerry S's Form 4 filing

Myriad Genetics Inc (MYGN) · filed Aug 25, 2021

Accession no.
0001219036-21-000024
Filed
Aug 25, 2021
Trade date
Aug 23-24, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.83M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lanchbury Jerry SCIK 0001219036Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 23, 2021Common StockMOption exerciseAcquired+10,000$27.07+$270,700242,550Direct
Aug 23, 2021Common StockSSaleDisposed−10,000$35.57−$355,700232,550Direct
Aug 23, 2021Common StockMOption exerciseAcquired+40,000$27.07+$1,082,800272,550Direct
Aug 23, 2021Common StockSSaleDisposed−40,000$35.07−$1,402,800232,550Direct
Aug 24, 2021Common StockMOption exerciseAcquired+30,000$27.07+$812,100262,550Direct
Aug 24, 2021Common StockSSaleDisposed−30,000$35.57−$1,067,100232,550Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 23, 2021Common StockMOption exerciseDisposed−10,000$0.00$070,000Direct
Aug 23, 2021Common StockMOption exerciseDisposed−40,000$0.00$030,000Direct
Aug 24, 2021Common StockMOption exerciseDisposed−30,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)